par Delaunoit, Thierry 
;Rubin, Joseph;Neczyporenko, Florence ;Erlichman, Charles;Hobday, Timothy J
Référence Mayo Clinic proceedings, 80, 4, page (502-506)
Publication Publié, 2005-04
;Rubin, Joseph;Neczyporenko, Florence ;Erlichman, Charles;Hobday, Timothy JRéférence Mayo Clinic proceedings, 80, 4, page (502-506)
Publication Publié, 2005-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Delaunoit, Thierry; Rubin, Joseph; Neczyporenko, Florence; Erlichman, Charles; Hobday, Timothy J |
| Informations sur la publication: | Mayo Clinic proceedings, 80, 4, page (502-506) |
| Statut de publication: | Publié, 2005-04 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Drug Therapy, Combination |
| Humans | |
| Interferon-alpha -- therapeutic use | |
| Neuroendocrine Tumors -- drug therapy | |
| Octreotide -- analogs & derivatives -- therapeutic use | |
| Pancreatic Neoplasms -- drug therapy | |
| Somatostatin -- analogs & derivatives -- therapeutic use | |
| Stomach Neoplasms -- drug therapy | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0025-6196 |
| info:doi/10.1016/S0025-6196(11)63202-3 | |
| info:pii/S0025-6196(11)63202-3 | |
| info:scp/16344392964 | |
| info:pmid/15819288 |
